Merdeka Battery Materials (MBMA)

Earnings Acceleration on Stronger Monetization and Downstream Execution

 

  • RKAB approval remains pending, though mgmt. expects downstream ore needs of ~23mn wmt to be secured.
  • We lift FY26F-27F net profit by 135-47%, driven by higher HGNM volume and stronger nickel price assumptions.
  • We maintain Buy with a higher TP of Rp940, supported by stronger FY26F-27F earnings trajectory and expanding EBITDA earnings. 

 

All eyes on RKAB Approval

In our latest discussion with mgmt., MBMA indicated that official RKAB approval from MEMR has yet to be received. Nonetheless, management remains confident that downstream ore requirements of c.23mn wmt will be secured, comprising 7–8mn wmt of saprolite and 10–15mn wmt of limonite. For FY26F, the key priority will shift toward cash flow stabilization, particularly amid the planned overhaul of 1–2 RKEF lines. Operationally, this implies softer seasonality in 1H26F, with production and earnings momentum expected to recover in 2H26F. 

 

Operational update and strategic development

Mgmt. highlighted that its HGNM operation has resumed under a more favorable contract structure with improved payability of ~90% from LME (vs. 88% previously), supporting incremental margin expansion. From the upstream side, effective 1st January 2026, limonite will be sold at market-based pricing of ~US$20/wmt (grade 1.15%), with estimated margins of US$10-11/wmt. On downstream side, MBMA plans to consolidate ESG (3Q26F) and SLNC (2H26F) after four consecutive quarters of positive EBITDA, requiring ~US$100mn and ~US$300mn respectively with funding from internal cash flow. Overall, these developments reinforce MBMA’s strategy to enhance vertical integration, strengthen margin resilience, and accelerate downstream monetization across the nickel value chain.

 

Maintain Buy rating with a higher TP of Rp940.

We raise our forecast for MBMA, incorporating a base-case nickel price assumption of US$17.5k/t in FY26F, higher HGNM volume of 50kt Ni in FY26F, and a more optimal HPAL contribution. As a result, we now project Net Profit to reach US$176mn in FY26F (+47% y-y) and US$379 in FY27F, with EBITDA margin expanding to 22.6%-26.2%. We set a higher TP of Rp940 based on SOTP, implying FY26F EV/EBITDA of 8.7x (c.-1std.dev 3-year average of 21.2x). Key downside risks include nickel price normalization, HPAL projects execution delays and RKAB uncertainty.

 

… Read More 20260304 MBMA